IL164220A0 - Collagen biofabric and methods of preparation and use therefor - Google Patents

Collagen biofabric and methods of preparation and use therefor

Info

Publication number
IL164220A0
IL164220A0 IL16422003A IL16422003A IL164220A0 IL 164220 A0 IL164220 A0 IL 164220A0 IL 16422003 A IL16422003 A IL 16422003A IL 16422003 A IL16422003 A IL 16422003A IL 164220 A0 IL164220 A0 IL 164220A0
Authority
IL
Israel
Prior art keywords
preparation
methods
collagen biofabric
use therefor
biofabric
Prior art date
Application number
IL16422003A
Other languages
English (en)
Original Assignee
Anthrogenesis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anthrogenesis Corp filed Critical Anthrogenesis Corp
Publication of IL164220A0 publication Critical patent/IL164220A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C12N2533/92—Amnion; Decellularised dermis or mucosa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/20—Coated or impregnated woven, knit, or nonwoven fabric which is not [a] associated with another preformed layer or fiber layer or, [b] with respect to woven and knit, characterized, respectively, by a particular or differential weave or knit, wherein the coating or impregnation is neither a foamed material nor a free metal or alloy layer
    • Y10T442/2525—Coating or impregnation functions biologically [e.g., insect repellent, antiseptic, insecticide, bactericide, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
IL16422003A 2002-03-26 2003-03-26 Collagen biofabric and methods of preparation and use therefor IL164220A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/106,653 US20030187515A1 (en) 2002-03-26 2002-03-26 Collagen biofabric and methods of preparing and using the collagen biofabric
PCT/US2003/009304 WO2003082201A2 (en) 2002-03-26 2003-03-26 Collagen biofabric and methods of preparation and use therefor

Publications (1)

Publication Number Publication Date
IL164220A0 true IL164220A0 (en) 2005-12-18

Family

ID=28452543

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16422003A IL164220A0 (en) 2002-03-26 2003-03-26 Collagen biofabric and methods of preparation and use therefor
IL164220A IL164220A (en) 2002-03-26 2004-09-22 Animal-collagenous fabric Methods of manufacture and / or use and products manufactured from it

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL164220A IL164220A (en) 2002-03-26 2004-09-22 Animal-collagenous fabric Methods of manufacture and / or use and products manufactured from it

Country Status (16)

Country Link
US (2) US20030187515A1 (zh)
EP (4) EP1575572B1 (zh)
JP (3) JP4615223B2 (zh)
KR (1) KR100999247B1 (zh)
CN (1) CN1791331A (zh)
AU (3) AU2003226018B2 (zh)
CA (1) CA2479903C (zh)
DK (2) DK2700309T3 (zh)
ES (2) ES2710024T3 (zh)
HK (1) HK1085384A1 (zh)
IL (2) IL164220A0 (zh)
MX (1) MXPA04009188A (zh)
NZ (1) NZ535799A (zh)
PT (1) PT2702871T (zh)
WO (1) WO2003082201A2 (zh)
ZA (1) ZA200407650B (zh)

Families Citing this family (263)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
EP2322601A1 (en) * 2000-12-06 2011-05-18 Anthrogenesis Corporation Method of collecting placental stem cells
CA2438153C (en) * 2001-02-14 2015-06-02 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
EP2338983B1 (en) * 2001-02-14 2015-10-07 Anthrogenesis Corporation Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
US6942802B2 (en) * 2001-04-13 2005-09-13 Wyeth Holdings Corporation Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
JP3888573B2 (ja) * 2001-06-29 2007-03-07 富士電機ホールディングス株式会社 ハンダ組成物
US7682803B2 (en) 2005-10-13 2010-03-23 Anthrogenesis Corporation Immunomodulation using placental stem cells
US7498171B2 (en) * 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
MXPA04009997A (es) * 2002-04-12 2004-12-13 Celgene Corp Modulacion de la diferenciacion de celulas madre y progenitoras, ensayos y usos de las mismas.
WO2003086373A1 (en) * 2002-04-12 2003-10-23 Celgene Corporation Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
KR20050086780A (ko) 2002-11-26 2005-08-30 안트로제네시스 코포레이션 세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
GB0321337D0 (en) * 2003-09-11 2003-10-15 Massone Mobile Advertising Sys Method and system for distributing advertisements
GB0322145D0 (en) * 2003-09-22 2003-10-22 Howmedica Internat S De R L Apparatus for use in the regeneration of structured human tissue
ES2403357T3 (es) 2003-12-11 2013-05-17 Isto Technologies Inc. Sistema de cartílago particulado
US7775965B2 (en) * 2004-03-09 2010-08-17 The Board Of Regents Of The University Of Oklahoma Decellularized grafts from umbilical cord vessels and process for preparing and using same
US20050287223A1 (en) * 2004-06-23 2005-12-29 Peyman Gholam A Use of amniotic membrane as biocompatible devices
US8802651B2 (en) * 2004-06-30 2014-08-12 Abbott Medical Optics Inc. Hyaluronic acid in the enhancement of lens regeneration
US8512730B2 (en) 2004-07-12 2013-08-20 Isto Technologies, Inc. Methods of tissue repair and compositions therefor
US20060190017A1 (en) * 2004-11-19 2006-08-24 Cyr John S Fibrin sealants and platelet concentrates applied to effect hemostasis at the interface of an implantable medical device with body tissue
JP2006176499A (ja) * 2004-11-25 2006-07-06 Nippon Seibutsu Seizai:Kk 眼疾患治療剤
US20070015685A1 (en) * 2005-04-04 2007-01-18 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
WO2006129673A1 (ja) * 2005-05-30 2006-12-07 Arblast Co., Ltd. 組織再建用材料及びその使用
KR20080026198A (ko) * 2005-06-30 2008-03-24 안트로제네시스 코포레이션 태반 유도된 콜라겐 바이오패브릭을 사용한 고막의 복원
EP1919500A2 (en) * 2005-07-13 2008-05-14 Anthrogenesis Corporation Treatment of leg ulcers using placenta derived collagen biofabric
WO2007009061A2 (en) * 2005-07-13 2007-01-18 Anthrogenesis Corporation Ocular plug formed from placenta derived collagen biofabric
GB0514567D0 (en) * 2005-07-15 2005-08-24 Univ Nottingham Surgical membrane
US7837673B2 (en) 2005-08-08 2010-11-23 Innovative Therapies, Inc. Wound irrigation device
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
WO2007023750A1 (ja) * 2005-08-26 2007-03-01 National University Corporation University Of Toyama 乾燥羊膜及び羊膜の乾燥処理方法
JP4977345B2 (ja) * 2005-08-26 2012-07-18 国立大学法人富山大学 乾燥羊膜及び羊膜の乾燥処理方法
US20070074980A1 (en) * 2005-09-02 2007-04-05 Bankoski Brian R Implant rehydration packages and methods of use
US7682304B2 (en) * 2005-09-21 2010-03-23 Medtronic, Inc. Composite heart valve apparatus manufactured using techniques involving laser machining of tissue
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
EP1933852B1 (en) 2005-09-27 2018-12-19 TissueTech, Inc. Amniotic membrane preparations and purified compositions and methods of use
NZ567334A (en) * 2005-10-13 2012-08-31 Anthrogenesis Corp Production of oligodendrocytes from placenta-derived stem cells
AU2006305989B2 (en) 2005-10-26 2013-10-24 Genesis Technologies Limited Acellular bioabsorbable tissue regeneration matrices produced by incubating acellular blood products
CN101395266B (zh) 2005-12-29 2018-06-15 人类起源公司 胎盘干细胞群
CA2633980A1 (en) * 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
CN101389754A (zh) 2005-12-29 2009-03-18 人类起源公司 胎盘干细胞和第二来源干细胞的联合培养
US20080044848A1 (en) * 2006-06-09 2008-02-21 Heidaran Mohammad A Placental niche and use thereof to culture stem cells
US7993918B2 (en) 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
WO2008021391A1 (en) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
WO2008042441A1 (en) * 2006-10-03 2008-04-10 Anthrogenesis Corporation Use of umbilical cord biomaterial for ocular surgery
US8071135B2 (en) 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
JP5769925B2 (ja) 2006-10-06 2015-08-26 アントフロゲネシス コーポレーション ヒト胎盤コラーゲン組成物、並びにそれらの製造方法及び使用方法
AU2013203211B2 (en) * 2006-10-06 2015-05-28 Celularity Inc. Native (telopeptide) placental collagen compositions
CN101631852A (zh) 2006-10-23 2010-01-20 人类起源公司 用胎盘细胞群治疗骨缺损的方法和组合物
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US20100136082A1 (en) * 2006-12-22 2010-06-03 Laboratoire Medidom S.A. In situ system for intra-articular chondral and osseous tissue repair
KR100795708B1 (ko) * 2006-12-26 2008-01-17 주식회사 알앤엘바이오 인간 양막 상피세포 유래 성체 줄기세포의 분리 및 배양방법
WO2008100497A1 (en) 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
EP2630959A1 (en) 2007-02-12 2013-08-28 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
WO2008128075A1 (en) 2007-04-12 2008-10-23 Isto Technologies, Inc. Compositions and methods for tissue repair
CA2684011A1 (en) * 2007-04-16 2008-10-23 Tissue Science Laboratories Plc Decellularised collagen-containing matrix for guided tissue regeneration
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
DE102007037051A1 (de) * 2007-07-24 2009-01-29 Aesculap Ag Flächiges Implantat
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
CA2736663C (en) * 2007-09-07 2018-01-02 Surgical Biologics, Llc. Placental tissue grafts and improved methods of preparing and using the same
US20090069843A1 (en) * 2007-09-10 2009-03-12 Agnew Charles W Fistula plugs including a hydration resistant component
RU2010116271A (ru) * 2007-09-26 2011-11-10 Селджин Селльюлар Терапьютикс (Us) Ангиогенные клетки из плацентарного перфузата человека
KR20210127819A (ko) * 2007-09-28 2021-10-22 안트로제네시스 코포레이션 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
KR20220098055A (ko) * 2007-11-07 2022-07-08 셀룰래리티 인코포레이티드 조산 합병증의 치료에 있어서의 제대혈의 용도
MX2010005791A (es) * 2007-11-28 2010-08-10 Organogenesis Inc Construcciones de tejido hechas mediante bio-ingenieria y metodos para produccion y uso.
US20090163990A1 (en) * 2007-12-19 2009-06-25 Chunlin Yang Decellularized omentum matrix and uses thereof
KR101683042B1 (ko) 2008-04-04 2016-12-06 포사이트 비젼4, 인크. 통증 관리 및 시력을 위한 치료 장치
CN104491845A (zh) 2008-04-18 2015-04-08 科尔普兰特有限公司 产生和使用原胶原的方法
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
AU2009240564A1 (en) * 2008-04-25 2009-10-29 Allosource Anti-adhesion barrier wound dressing comprising processed amniotic tissue and method of use
US9358320B2 (en) 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
AU2009277252B2 (en) * 2008-07-30 2014-01-16 Mesynthes Limited Tissue scaffolds derived from forestomach extracellular matrix
US20100080840A1 (en) * 2008-07-31 2010-04-01 Michael Cho Hybrid superporous hydrogel scaffold for cornea regeneration
RU2558778C2 (ru) * 2008-08-20 2015-08-10 Антродженезис Корпорейшн Лечение инсульта с использованием изолированных плацентарных клеток
KR20210010648A (ko) 2008-08-20 2021-01-27 안트로제네시스 코포레이션 개선된 세포 조성물 및 그의 제조 방법
EP2331109B1 (en) 2008-08-22 2013-05-29 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
US8858698B2 (en) * 2008-09-05 2014-10-14 Mentor Worldwide Llc Acellular matrix glue
US7927414B2 (en) * 2008-09-05 2011-04-19 Ethicon, Inc. Method of manufacturing acellular matrix glue
EP2367932B1 (en) 2008-11-19 2019-06-12 Celularity, Inc. Amnion derived adherent cells
NZ592839A (en) * 2008-11-21 2012-10-26 Anthrogenesis Corp Treatment of diseases, disorders or conditions of the lung using placental cells
JP5693475B2 (ja) * 2009-03-04 2015-04-01 ペイタント・ソリューションズ・インコーポレイテッドＰｅｙｔａｎｔ Ｓｏｌｕｔｉｏｎｓ， Ｉｎｃ． 羊膜組織を含む材料で修飾されたステント及び対応する方法
AU2010229711B2 (en) 2009-03-25 2015-06-04 Celularity Inc. Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
US9039783B2 (en) * 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
WO2010141654A1 (en) 2009-06-05 2010-12-09 Anthrogenesis Corporation Improved method of collecting placental cells
CA2767014C (en) 2009-07-02 2022-01-25 Anthrogenesis Corporation Method of producing erythrocytes without feeder cells
KR101103571B1 (ko) * 2009-09-23 2012-01-09 한림대학교 산학협력단 피부조직 재생용 구조체 및 이를 이용한 인공피부
EP2490635B1 (en) 2009-10-23 2017-09-06 Nexisvision, Inc. Corneal denervation for treatment of ocular pain
US9498385B2 (en) 2009-10-23 2016-11-22 Nexisvision, Inc. Conformable therapeutic shield for vision and pain
WO2011074208A1 (ja) * 2009-12-18 2011-06-23 国立大学法人東北大学 皮膚真皮又は羊膜透明化による角膜移植材料調製法
WO2011094181A1 (en) 2010-01-26 2011-08-04 Anthrogenesis Corporation Treatment of bone-related cancers using placental stem cells
EP2536825B1 (en) 2010-02-18 2024-03-27 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products
CN107699541A (zh) 2010-04-07 2018-02-16 人类起源公司 使用胎盘干细胞的血管生成
MX2012011543A (es) 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8840665B2 (en) 2010-06-11 2014-09-23 Liventa Bioscience, Inc. Method of tendon repair with amnion and chorion constructs
WO2012003377A2 (en) * 2010-06-30 2012-01-05 Tissuetech, Inc. Methods of preparing chorion tissue and products derived therefrom
CN103068413B (zh) * 2010-07-08 2015-12-16 生命细胞公司 用于使组织基质成形的方法
KR20200077613A (ko) 2010-07-13 2020-06-30 안트로제네시스 코포레이션 천연 킬러 세포의 생성 방법
US20120035743A1 (en) * 2010-08-03 2012-02-09 AFcell Medical Amnion and chorion constructs and uses thereof in minimally invasive surgeries
US8435305B2 (en) 2010-08-31 2013-05-07 Zimmer, Inc. Osteochondral graft delivery device and uses thereof
US9433490B2 (en) 2010-12-22 2016-09-06 University Of Florida Research Foundation, Inc. Multilayered implant materials derived from amniotic membrane, methods of making the multilayered implant materials, and method of using multilayered implant materials
WO2012092480A1 (en) 2010-12-30 2012-07-05 Anthirogenesis Corporation Compositions comprising amnion derived adherent cells and platelet-rich plasma
AR084754A1 (es) 2010-12-30 2013-06-05 Anthrogenesis Corp Composiciones que comprenden celulas madre de placenta y plasma rico en plaquetas, y sus metodos de uso
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
CA2826359A1 (en) 2011-02-14 2012-08-23 Mimedx Group Inc. Tissue grafts modified with a cross-linking agent and methods of making and using the same
EP2585084A4 (en) 2011-02-14 2014-12-31 Mimedx Group Inc MICRONIZED PLAZENTAGE WOVEN COMPOSITIONS AND METHOD FOR THEIR MANUFACTURE AND USE
AU2012217975B2 (en) * 2011-02-14 2015-11-19 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
US12044905B2 (en) 2011-04-28 2024-07-23 Journey1 Inc Contact lenses for refractive correction
ES2707579T3 (es) 2011-06-01 2019-04-04 Celularity Inc Tratamiento del dolor usando citoblastos placentarios
CA2837878A1 (en) 2011-06-10 2012-12-13 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
US9925221B2 (en) 2011-09-09 2018-03-27 Celularity, Inc. Treatment of amyotrophic lateral sclerosis using placental stem cells
US20130136773A1 (en) * 2011-09-30 2013-05-30 NuTech Spine, Inc. Expandable Placental Membrane and Methods of Making and Storing Same
US10517902B2 (en) * 2011-09-30 2019-12-31 Prime Merger Sub, Llc Expandable amnion membrane for treating non-healing wounds
US9585983B1 (en) * 2011-10-12 2017-03-07 BioDlogics, LLC Wound covering and method of preparation
EP2785360B1 (en) 2011-12-02 2019-06-19 MIMEDX Group Inc. Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using same
US9162011B2 (en) 2011-12-19 2015-10-20 Allosource Flowable matrix compositions and methods
EP2793745B1 (en) 2011-12-22 2019-07-31 MIMEDX Group Inc. Cross-linked dehydrated placental tissue grafts and methods for making and using the same
US20150017140A1 (en) * 2011-12-23 2015-01-15 Anthrogenesis Corporation Organoids comprising decellularized and repopulated placental vascular scaffold
US9416410B2 (en) * 2012-02-14 2016-08-16 Genetics Development Corporation Cutoff point delta Ct. method for HER2 PCR testing in breast cancer
US9575054B2 (en) * 2012-02-23 2017-02-21 Anthrogenesis Corporation Identification of antitumor compounds using placenta
US10071184B2 (en) 2012-02-29 2018-09-11 Collagen Matrix, Inc. Collagen-coated tissue-based membranes
US8961617B2 (en) 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
US20180126033A9 (en) 2012-03-14 2018-05-10 MAM Holdings of West Florida, L.L.C. Collagen compositions and uses for biomaterial implants
US10576037B2 (en) * 2012-03-14 2020-03-03 MAM Holdings of West Florida, L.L.C. Compositions comprising placental collagen for use in wound healing
KR101404089B1 (ko) * 2012-04-02 2014-06-05 원광대학교산학협력단 양막 추출물을 함유하는 이중층 하이드로겔 습윤드레싱 및 그 제조방법
KR20220166873A (ko) 2012-08-13 2022-12-19 셀룰래리티 인코포레이티드 자연 살해 세포 및 그의 용도
US8904664B2 (en) 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
EP2884944B1 (en) * 2012-08-15 2020-10-07 MiMedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
KR20220093401A (ko) 2012-09-04 2022-07-05 셀룰래리티 인코포레이티드 조직 생성 방법
RU2015112289A (ru) * 2012-09-04 2016-10-27 Антродженезис Корпорейшн Способы создания тканей
WO2014040026A2 (en) 2012-09-10 2014-03-13 Wake Forest University Health Sciences Amniotic membrane and its use in wound healing and tissue engineering constructs
US9180145B2 (en) 2012-10-12 2015-11-10 Mimedx Group, Inc. Compositions and methods for recruiting and localizing stem cells
US10245306B2 (en) 2012-11-16 2019-04-02 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
US9155799B2 (en) 2012-11-19 2015-10-13 Mimedx Group, Inc. Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
US8946163B2 (en) 2012-11-19 2015-02-03 Mimedx Group, Inc. Cross-linked collagen comprising metallic anticancer agents
US8940684B2 (en) 2012-11-19 2015-01-27 Mimedx Group, Inc. Cross-linked collagen comprising an antifungal agent
CA2894160C (en) * 2012-12-07 2024-01-02 Anthrogenesis Corporation Treating oral lesions using placental extracellular matrix
EP2938196B1 (en) 2012-12-14 2019-04-03 Celularity, Inc. Anoikis resistant placental stem cells and uses thereof
AU2013204922B2 (en) 2012-12-20 2015-05-14 Celgene Corporation Chimeric antigen receptors
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
CN103006349A (zh) * 2012-12-26 2013-04-03 天津市赛宁生物工程技术有限公司 体外培养的组织工程血管
CN105246495B (zh) 2013-01-09 2021-08-10 Ise专业检测与咨询服务有限公司 来自非哺乳动物组织的脱细胞化的生物材料
US9827293B2 (en) 2013-01-17 2017-11-28 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US9655948B1 (en) 2013-01-17 2017-05-23 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
US10517931B2 (en) 2013-01-17 2019-12-31 Mimedx Group, Inc. Non-surgical, localized delivery of compositions for placental growth factors
WO2014113733A1 (en) 2013-01-18 2014-07-24 Mimedx Group, Inc. Methods for treating cardiac conditions
US10206977B1 (en) 2013-01-18 2019-02-19 Mimedx Group, Inc. Isolated placental stem cell recruiting factors
US10905800B1 (en) 2013-01-29 2021-02-02 BioDlogics, LLC Ocular covering and method of use
WO2014120946A1 (en) * 2013-01-30 2014-08-07 NuTech Medical, Inc. Placental membrane preparation and methods of making and using same
CN103127549A (zh) * 2013-02-01 2013-06-05 中山大学中山眼科中心 一种脱细胞睑板及其制备方法
JP2016506968A (ja) 2013-02-05 2016-03-07 アントフロゲネシス コーポレーション 胎盤由来のナチュラルキラー細胞
US9498327B1 (en) 2013-03-05 2016-11-22 Biodlogics Llc Repair of tympanic membrane using human birth tissue material
US9789138B1 (en) 2013-03-06 2017-10-17 BioDlogics, LLC Neural repair construct and method of use
US9770472B1 (en) 2013-03-08 2017-09-26 Brahm Holdings, Llc Organ jacket and methods of use
WO2014164900A1 (en) 2013-03-13 2014-10-09 Allosource Fascia fibrous compositions and methods for their use and manufacture
US9855301B1 (en) 2013-03-13 2018-01-02 Biodlogics Llc Human birth tissue laminate and methods of use
WO2014159806A1 (en) 2013-03-14 2014-10-02 Anthrogenesis Corporation Enhanced placental stem cells and uses thereof
CA2901841A1 (en) 2013-03-15 2014-09-18 NuTech Medical, Inc. Preparations derived from placental materials and methods of making and using same
US10029030B2 (en) * 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
NO2975611T3 (zh) 2013-03-15 2018-06-09
CA2899713C (en) 2013-03-15 2022-07-19 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
US9795638B1 (en) 2013-03-16 2017-10-24 BioDlogics, LLC Cardiothoracic construct and methods of use
CN104083803B (zh) * 2013-04-01 2016-04-27 陕西佰傲再生医学有限公司 一种用于眼表修复的生物膜及其制备方法
US10335433B2 (en) 2013-04-10 2019-07-02 Mimedx Group, Inc. NDGA polymers and metal complexes thereof
WO2014189835A2 (en) * 2013-05-20 2014-11-27 Yale University Anti-thrombogenic grafts
US9446142B2 (en) 2013-05-28 2016-09-20 Mimedx Group, Inc. Polymer chelator conjugates
EP3862422A1 (en) 2013-06-24 2021-08-11 Celularity Inc. Extracellular matrix composition beads for cell culture
CA2916885A1 (en) 2013-06-26 2014-12-31 Nexisvision, Inc. Contact lenses for refractive correction
JP6756612B2 (ja) 2013-08-30 2020-09-16 ミメディクス グループ インコーポレイテッド キレーターを含む微粒子化した胎盤性組成物
EP2857350A1 (en) * 2013-09-10 2015-04-08 ESPCI Innov Use of nanoparticles for gluing gels
WO2015085232A1 (en) 2013-12-06 2015-06-11 Allosource Method of drying sheets of tissue
AU2015206236B2 (en) 2014-01-17 2020-02-20 Mimedx Group, Inc. Method for inducing angiogenesis
WO2015120405A1 (en) * 2014-02-07 2015-08-13 Amniolife Corporation Patterned tissue membranes and methods and system for their preparation
US9132156B1 (en) * 2014-06-15 2015-09-15 Amnio Technology Llc Acellular amnion derived therapeutic compositions
US10894066B2 (en) 2014-03-06 2021-01-19 Amnio Technology Llc Amnion derived therapeutic compositions and methods of use
US9801910B2 (en) * 2014-03-17 2017-10-31 Ethicon, Inc. Decellularized pleural matrix
CN103861151B (zh) * 2014-03-27 2016-03-30 成都青山利康药业有限公司 一种脱细胞胎盘基质材料的制备方法
WO2015171144A1 (en) * 2014-05-07 2015-11-12 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products
SG11201609254YA (en) * 2014-05-07 2016-12-29 Osiris Therapeutics Inc Therapeutic placental compositions, methods of making and methods of use
WO2015175776A1 (en) 2014-05-14 2015-11-19 NuTech Medical, Inc. Placental membrane preparations and methods of making and using same for regenerating cartilage and spinal intervertebral discs
CN113249297A (zh) 2014-05-28 2021-08-13 儿童医院医疗中心 用于经由定向分化将前体细胞转化为胃组织的方法和系统
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
US10363278B2 (en) 2014-06-15 2019-07-30 Amnio Technology Llc Frozen therapeutic dose and package
CN115531551A (zh) * 2014-07-29 2022-12-30 黄玲惠 含胶原蛋白与透明质酸的细胞组织胶体
WO2016033385A1 (en) 2014-08-28 2016-03-03 Mimedx Group, Inc. Collagen reinforced tissue grafts
AU2015328014B2 (en) 2014-10-02 2020-11-12 Wake Forest University Health Sciences Amniotic membrane powder and its use in wound healing and tissue engineering constructs
US10179191B2 (en) 2014-10-09 2019-01-15 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
JP2017531495A (ja) * 2014-10-10 2017-10-26 オーソセル・リミテッド 軟組織の無縫合修復
US11584916B2 (en) 2014-10-17 2023-02-21 Children's Hospital Medical Center Method of making in vivo human small intestine organoids from pluripotent stem cells
US10265438B1 (en) 2014-11-03 2019-04-23 BioDlogics, LLC Methods and compositions for the repair and replacement of connective tissue
US10765705B2 (en) 2014-11-24 2020-09-08 Prime Merger Sub, Llc Visco-supplement compositions, and methods of use thereof
JP6797803B2 (ja) 2014-12-31 2020-12-09 セルジーン コーポレイション ナチュラルキラー細胞を用いて血液障害、固形腫瘍、又は感染性疾患を治療する方法
US10342830B2 (en) 2015-01-05 2019-07-09 Gary M. Petrucci Methods and materials for treating lung disorders
US10736990B2 (en) * 2015-02-11 2020-08-11 Mimedx Group, Inc. Collagen and micronized placental tissue compositions and methods of making and using the same
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
US11028362B2 (en) * 2015-04-17 2021-06-08 The Regents Of The University Of California Decellularized human amniotic membrane for cell delivery, cell culture and inflammation prevention
CN104826166B (zh) * 2015-05-06 2017-06-06 广州优适清生物科技有限公司 一种用于青光眼治疗的生物膜及其制备方法
CN107847526A (zh) 2015-05-20 2018-03-27 组织技术公司 用于预防上皮细胞的增殖和上皮‑间充质转换的组合物和方法
CA3177726A1 (en) 2015-05-21 2016-11-24 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
CN105169493B (zh) * 2015-07-13 2018-02-27 江南大学 一种人工异种皮肤的制备方法
US10517903B2 (en) 2015-09-14 2019-12-31 Amnio Technology Llc Amnion derived therapeutic composition and process of making same
MX2018003275A (es) 2015-09-15 2018-05-16 Celularity Inc Tratamiento de la neuropatia periferica diabetica utilizando celulas placentarias.
JP2018527394A (ja) 2015-09-23 2018-09-20 オシリス セラピューティクス，インコーポレイテッド 臍組織組成物及び使用方法
WO2017059089A1 (en) * 2015-09-29 2017-04-06 Anicell Biotech, Llc Methods and articles of manufacture for the treatment of animals
EP3367966A4 (en) 2015-10-30 2019-07-10 New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital for Special Surgery SUSPENDED PATH AND METHOD FOR ADMINISTRATION WITHIN AN EXISTING ARTHROSCOPIC WORKFLOW
US20170136070A1 (en) * 2015-11-18 2017-05-18 Dregalla Patent Holdco, LLC Acellular Regenerative Products and Methods of Their Manufacture
KR20180095913A (ko) * 2015-12-23 2018-08-28 라이프넷 헬스 탈세포화된 태반막 및 이의 제조 방법 및 용도
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
US11484401B2 (en) 2016-02-01 2022-11-01 Medos International Sarl Tissue augmentation scaffolds for use in soft tissue fixation repair
US10702260B2 (en) 2016-02-01 2020-07-07 Medos International Sàrl Soft tissue fixation repair methods using tissue augmentation scaffolds
WO2017136557A1 (en) 2016-02-05 2017-08-10 Petrucci Gary M Methods and materials for treating nerve injuries and neurological disorders
EP3452578B1 (en) 2016-05-05 2022-08-10 Children's Hospital Medical Center Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same
CN105833353B (zh) * 2016-05-09 2018-04-20 拜欧迪赛尔（北京）生物科技有限公司 一种生物工程脱细胞真皮基质的制备及用途
IL264536B2 (en) 2016-08-24 2023-09-01 Arthrex Inc Use of tissue for injury repair
US11577001B2 (en) * 2016-11-02 2023-02-14 Axogen Corporation Amnion tissue grafts and methods of preparing and using same
CN106390195B (zh) * 2016-11-16 2019-08-23 四川大学 一种胶原膜的改性方法
NZ753873A (en) 2016-12-05 2023-01-27 Children’S Hospital Medical Center Colonic organoids and methods of making and using same
AU2017373862A1 (en) 2016-12-05 2019-06-27 Celularity Inc. Treatment of lymphedema and related conditions using placental adherent cells
CN108210995A (zh) * 2016-12-14 2018-06-29 成都青山利康药业有限公司 一种新型的复合生物组织修复材料及其制备方法和用途
WO2018137041A1 (en) * 2017-01-26 2018-08-02 Dalhousie University Templated assembly of collagen fibers and uses thereof
US10772986B2 (en) 2017-01-26 2020-09-15 Allosource Fascia fibrous compositions and methods for their use and manufacture
EP3578189B1 (en) * 2017-02-03 2022-08-31 Biocellix SpA Collagen membrane or matrix with antimicrobial properties
CN107137768B (zh) * 2017-04-12 2020-07-07 苏州诺普再生医学有限公司 一种脱细胞羊膜粉的制备方法
JP7031138B2 (ja) 2017-05-11 2022-03-08 株式会社リコー 脱細胞化組織の製造方法、及び脱細胞化組織の製造装置
CN107233144A (zh) * 2017-05-31 2017-10-10 中山大学中山眼科中心 去细胞角膜基质透镜在治疗眼科疾病中的应用
US10478531B2 (en) 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
CN109481737B (zh) * 2017-09-12 2021-07-06 中国人民解放军第三军医大学第一附属医院 一种仿生双层敷料及其制备方法
US10251917B1 (en) * 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
US20200246393A1 (en) 2017-09-28 2020-08-06 Celularity, Inc. Tumor suppression using human placenta-derived intermediate natural killer (pink) cells in combination with an antibody
WO2019099503A1 (en) 2017-11-14 2019-05-23 Cook Biotech Incorporated Preserved tissue products and related methods
CN108051509B (zh) * 2017-11-21 2020-06-23 陈溉 一种治疗褥疮的药物的特征图谱检测方法及其应用
CN107929811A (zh) * 2017-12-15 2018-04-20 厦门大学 一种组织工程角膜
WO2019165320A1 (en) 2018-02-22 2019-08-29 Celularity, Inc. Post partum tissue-derived induced pluripotent stem cells and uses thereof
US11602548B1 (en) 2018-02-26 2023-03-14 Convatec, Inc Fibrous birth tissue composition and method of use
CN109065670B (zh) * 2018-08-08 2019-12-20 长春长光宇航复合材料有限公司 碳纤维复合材料网格蒙皮太阳能电池阵基板的制备方法
JP2022511786A (ja) 2018-11-30 2022-02-01 セルラリティ インク． 新規芳香族化合物によるナチュラルキラー細胞およびｉｌｃ３細胞の増殖
CN109557107A (zh) * 2018-12-29 2019-04-02 南工大溧阳新材料研发中心有限公司 一种不锈钢/碳钢复合材料的探伤检测方法
US11511017B2 (en) 2019-03-12 2022-11-29 Arthrex, Inc. Ligament reconstruction
WO2020252464A1 (en) 2019-06-14 2020-12-17 Celularity Inc. Populations of natural killer cells for treating cancers
WO2021016621A1 (en) 2019-07-25 2021-01-28 Celularity Inc. Populations of natural killer cells comprising a cd38 chimeric antigen receptor
US20230355759A1 (en) 2019-07-31 2023-11-09 Celularity Inc. Populations of natural killer cells comprising a cleavage resistant cd16
CN110404119B (zh) * 2019-08-29 2023-04-07 上海越增生物科技有限公司 羊膜组织工程去免疫原皮肤支架的制备方法
WO2021113849A1 (en) 2019-12-05 2021-06-10 Celularity Inc. Her2+ cancer treatment with populations of natural killer cells comprising a cleavage resistant cd16
WO2021155312A1 (en) 2020-01-29 2021-08-05 Celularity Inc. Placental derived natural killer cells for treatment of coronavirus infections
US20210244845A1 (en) * 2020-02-10 2021-08-12 Leslie MARCELIN Method Of Processing Amnion To Form A Suture
MX2022009961A (es) 2020-02-14 2022-11-14 Kheiros Pater Inovacao S A Método para producir biomaterial descelularizado, material descelularizado y usos de este.
EP4125749A4 (en) * 2020-04-03 2024-05-08 BioTissue Holdings Inc. METHOD OF USING UMBILICAL CORD PRODUCTS FOR THE TREATMENT OF OCULAR SURFACE DISEASES
WO2021226602A1 (en) 2020-05-08 2021-11-11 Celularity Inc. Placenta-derived adherent (pda) stem cell for the treatment of adults with sars-cov-2 related acute respiratory failure and ards (covid-19)
TW202233828A (zh) 2020-11-12 2022-09-01 日商Ａｄｅｋａ股份有限公司 去細胞化組織組成物
CN112641999B (zh) * 2020-12-04 2022-10-04 陕西佰傲再生医学有限公司 一种铺膜设备及其应用
KR20230118861A (ko) * 2020-12-11 2023-08-14 오스테오지닉스 바이오메디칼, 인크. 다중-층 콜라겐-기반 막
MX2023012051A (es) * 2021-04-13 2024-01-08 Celularity Inc Injertos tisulares amnioticos multicapa y usos de estos.
WO2023278628A1 (en) 2021-06-29 2023-01-05 Celularity Inc. Human placental hematopoietic stem cell derived natural killer cells in acute myeloid leukemia (aml) remission with minimal residual disease (mrd) or relapsed/refractory aml
CR20240104A (es) 2021-07-29 2024-06-28 Celularity Inc Células NK derivadas de la placenta como senolítico para usos terapéuticos y otros.
CN114028618A (zh) * 2021-10-25 2022-02-11 广东普洛宇飞生物科技有限公司 一种基于羊膜基底膜的生物材料及其制备方法和应用
AU2023206330A1 (en) 2022-01-11 2024-08-22 Celularity Inc. Cleavage resistant cd16 constructs and uses thereof
CN115054730B (zh) * 2022-06-14 2023-08-18 健诺维(成都)生物科技有限公司 一种羊膜新材料及其制备方法
WO2024167694A2 (en) * 2023-02-06 2024-08-15 Celularity Inc. Placental extracellular matrices for ocular delivery of ophthalmic therapeutic agents

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157524A (en) 1960-10-25 1964-11-17 Ethicon Inc Preparation of collagen sponge
US3800792A (en) 1972-04-17 1974-04-02 Johnson & Johnson Laminated collagen film dressing
DE2416313C3 (de) 1974-04-04 1978-11-23 Roland 8731 Euerdorf Satzinger Sicherheitseinrichtung für die Insassen von Fahrzeugen, insbesondere Kraftfahrzeugen
US4060081A (en) 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
DE2943520C2 (de) 1979-10-27 1982-05-19 Fa. Carl Freudenberg, 6940 Weinheim Verfahren zur Herstellung von Kollagenschwamm für medizinische oder kosmetische Zwecke
US4446234A (en) * 1981-10-23 1984-05-01 The United States Of America As Represented By The Department Of Health And Human Services Vitro cellular interaction with amnion membrane substrate
US4973493A (en) * 1982-09-29 1990-11-27 Bio-Metric Systems, Inc. Method of improving the biocompatibility of solid surfaces
US4883618A (en) 1983-02-02 1989-11-28 Minnesota Mining And Manufacturing Company Absorbable nerve repair device and method
US4837285A (en) 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
US4778467A (en) 1984-04-25 1988-10-18 The University Of Utah Prostheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas
IL78950A (en) * 1985-06-06 1991-12-15 Univ Jefferson Coating for prosthetic devices
JPS63260549A (ja) * 1987-04-17 1988-10-27 石川　統一 補綴材料およびその製造方法
EP0363400B1 (en) 1987-04-28 1993-03-03 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
US5036056A (en) * 1987-07-08 1991-07-30 Martin Kludas Methods for treating damaged corneal, uterine, or cartilage tissue
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
US5116620A (en) 1989-11-21 1992-05-26 Bruce A. Barber Antimicrobial wound dressing
US5308627A (en) 1990-08-07 1994-05-03 Umbdenstock Jr Anthony J Nutritional supplement for optimizing cellular health
US5198465A (en) 1991-06-19 1993-03-30 Dioguardi Francesco S Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen
EP0534152B1 (en) 1991-09-26 1996-11-06 United States Surgical Corporation Nerve repair device
US5418875A (en) 1992-09-04 1995-05-23 Honda Tsushin Kogyo Co., Ltd. Adapter for optical connector having float-type sleeve holder and panel fitting for mounting the same
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
JP3542170B2 (ja) * 1993-08-06 2004-07-14 株式会社アムニオテック 医用材料及びその製造方法
GB9400163D0 (en) 1994-01-06 1994-03-02 Geistlich Soehne Ag Membrane
IL112580A0 (en) * 1994-02-24 1995-05-26 Res Dev Foundation Amniotic membrane graft of wrap to prevent adhesions or bleeding of internal organs
US6203755B1 (en) * 1994-03-04 2001-03-20 St. Jude Medical, Inc. Electron beam sterilization of biological tissues
AU1931495A (en) * 1994-03-14 1995-10-03 Cryolife, Inc. Treated tissue for implantation and preparation methods
EP0734736A1 (en) 1995-03-31 1996-10-02 Toyo Boseki Kabushiki Kaisha Medical device and method for producing the same
JP2905718B2 (ja) * 1995-03-31 1999-06-14 東洋紡績株式会社 医用材料およびその製造方法
JPH09122227A (ja) 1995-10-31 1997-05-13 Bio Eng Lab:Kk 医用材料およびその製造方法
JP3476631B2 (ja) * 1995-12-21 2003-12-10 株式会社アムニオテック ヒト由来の天然コラーゲン膜からなる医用材料
WO1997045532A1 (en) * 1996-05-28 1997-12-04 Brown University Research Foundation Hyaluronan based biodegradable scaffolds for tissue repair
JP3563216B2 (ja) * 1996-10-14 2004-09-08 株式会社アムニオテック 医用代替膜及びその製造方法
US5804594A (en) 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
US6152142A (en) * 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US5993844A (en) * 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
US5932205A (en) * 1997-07-24 1999-08-03 Wang; Ming X. Biochemical contact lens for treating photoablated corneal tissue
US6143315A (en) * 1997-07-24 2000-11-07 Wang; Ming X. Biochemical contact lens for treating injured corneal tissue
US6371992B1 (en) * 1997-12-19 2002-04-16 The Regents Of The University Of California Acellular matrix grafts: preparation and use
US6432710B1 (en) * 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
US6734018B2 (en) * 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
US6312474B1 (en) * 1999-09-15 2001-11-06 Bio-Vascular, Inc. Resorbable implant materials
US6432712B1 (en) * 1999-11-22 2002-08-13 Bioscience Consultants, Llc Transplantable recellularized and reendothelialized vascular tissue graft
US6479064B1 (en) * 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
US6376244B1 (en) * 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
US6428802B1 (en) * 1999-12-29 2002-08-06 Children's Medical Center Corp. Preparing artificial organs by forming polylayers of different cell populations on a substrate
US6866686B2 (en) * 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
US6962814B2 (en) * 2000-08-16 2005-11-08 Duke University Decellularized tissue engineered constructs and tissues
WO2002022184A2 (en) * 2000-09-18 2002-03-21 Organogenesis Inc. Bioengineered flat sheet graft prosthesis and its use
EP1446015B1 (en) * 2001-10-18 2018-03-14 Lifecell Corporation Remodeling of tissues and organs
US7497602B2 (en) 2007-02-08 2009-03-03 Wen-Cheng Lien Three dimension collapsible lampshade

Also Published As

Publication number Publication date
EP2702871B1 (en) 2018-10-24
IL164220A (en) 2012-10-31
AU2003226018A1 (en) 2003-10-13
EP2700309B1 (en) 2019-06-05
AU2011201662A1 (en) 2011-05-12
ES2526088T3 (es) 2015-01-05
EP2700309A1 (en) 2014-02-26
EP2702871A1 (en) 2014-03-05
PT2702871T (pt) 2019-02-01
ES2710024T3 (es) 2019-04-22
NZ535799A (en) 2010-06-25
AU2011201662B2 (en) 2013-02-07
JP5931327B2 (ja) 2016-06-08
JP2010265298A (ja) 2010-11-25
WO2003082201A3 (en) 2005-11-10
CN1791331A (zh) 2006-06-21
JP4615223B2 (ja) 2011-01-19
AU2003226018B2 (en) 2008-03-13
KR100999247B1 (ko) 2010-12-07
EP1575572A2 (en) 2005-09-21
ZA200407650B (en) 2006-07-26
KR20050002906A (ko) 2005-01-10
EP3412322A1 (en) 2018-12-12
EP1575572A4 (en) 2010-10-13
WO2003082201A2 (en) 2003-10-09
JP2006507851A (ja) 2006-03-09
DK2700309T3 (da) 2019-09-16
DK2702871T3 (en) 2019-02-18
MXPA04009188A (es) 2005-06-20
JP2014138590A (ja) 2014-07-31
CA2479903C (en) 2016-08-23
HK1085384A1 (zh) 2006-08-25
EP1575572B1 (en) 2014-09-24
JP5993387B2 (ja) 2016-09-14
AU2008202604B2 (en) 2011-01-06
US20040048796A1 (en) 2004-03-11
CA2479903A1 (en) 2003-10-09
AU2008202604A1 (en) 2008-07-03
US20030187515A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
IL164220A0 (en) Collagen biofabric and methods of preparation and use therefor
AU2003207698A8 (en) Needle-suture combinations and methods of use
EP1465615A4 (en) TRICYCLIC BISENONE DERIVATIVES AND METHODS OF USE
HK1079789A1 (zh) 血管靜態毒性試劑及其使用方法
HK1067977A1 (en) Illuminated toothbrush and method of use
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
PL376532A1 (pl) Pochodne podstawionych benzyloamin oraz sposoby wykorzystania
AU2003259735A8 (en) Small-mer compositions and methods of use
AU2003300323A8 (en) Vascular prosthesis and methods of use
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003288902A8 (en) Microcapsules and methods of use
ZA200506790B (en) Arylvinylazacycloalkane compounds and method of preparation and use thereof
AU2003259717A8 (en) Modulators of rabggt and methods of use thereof
EP1476150A4 (en) CARBOXY FULLERES AND USE METHOD THEREFOR
EP1567515A4 (en) NEW LAPACHONE COMPOUNDS AND METHODS FOR THE APPLICATION
AU2003299441A8 (en) Nf-hev compositions and methods of use
AU2003240939A8 (en) Electroprocessed collagen and tissue engineering
PL373163A1 (en) Salt of (s)-pantoprazole and its hydrates
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
EP1545287A4 (en) VASOREGULATORY COMPOUNDS AND METHODS RELATING TO THEIR USE
AU2003294575A8 (en) Implant anchor and methods of use
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003216354A8 (en) Modulators of paraptosis and related methods
AU2003282593A8 (en) Polyphenolamine composition and method of use